{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T12:15:23Z","timestamp":1789992923462,"version":"4.0.1"},"reference-count":37,"publisher":"S. Karger AG","issue":"3-4","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.karger.com\/Services\/SiteLicenses"},{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.karger.com\/Services\/SiteLicenses"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuroepidemiology"],"published-print":{"date-parts":[[2014]]},"abstract":"<jats:p>&lt;b&gt;&lt;i&gt;Background:&lt;\/i&gt;&lt;\/b&gt; The Guillain-Barr\u00e9 syndrome (GBS) occurs after infections and as an adverse reaction to vaccines. No detailed information on incidence rates (IRs) in Germany is available. &lt;b&gt;&lt;i&gt;Methods:&lt;\/i&gt;&lt;\/b&gt; This retrospective cohort study estimated age- and sex-specific IRs of GBS in Germany in the years 2007-2009 based on electronic healthcare data from the German Pharmacoepidemiological Research Database (GePaRD). Two case definitions were applied. GBS cases had a main discharge diagnosis of GBS. GBS_PROCEDURE cases in addition had codes for relevant diagnostic procedures. Crude and standardized IRs (SIRs) with 95% confidence intervals were stratified by year, age group, sex, region and season. IR ratios (IRRs) for each stratification factor were calculated by multivariable Poisson regression. &lt;b&gt;&lt;i&gt;Results:&lt;\/i&gt;&lt;\/b&gt; Among 13,297,678 persons, 889 (693) incident GBS (GBS_PROCEDURE) cases were identified. Overall SIRs per 100,000 person years were 2.4 (2.2-2.5) for GBS and 1.8 (1.7-2.0) for GBS_PROCEDURE. (S)IRs increased with age, peaking in the age group 70-79 years (IR GBS: 5.5 (4.7-6.5)) and were higher in males than in females (e.g., IR GBS: IRR = 1.5 (1.3-1.7)) and in February-April, as compared to the rest of the year. No regional pattern was observed. &lt;b&gt;&lt;i&gt;Conclusion:&lt;\/i&gt;&lt;\/b&gt; (S)IRs of GBS in Germany differed by age, sex and season and were comparable to those found in other studies. Results might be used as a comparator in vaccine safety monitoring.<\/jats:p>","DOI":"10.1159\/000369344","type":"journal-article","created":{"date-parts":[[2014,12,16]],"date-time":"2014-12-16T07:57:33Z","timestamp":1418716653000},"page":"244-252","source":"Crossref","is-referenced-by-count":23,"title":["Estimation of Background Incidence Rates of Guillain-Barr\u00e9 Syndrome in Germany - A Retrospective Cohort Study with Electronic Healthcare Data"],"prefix":"10.1159","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4742-0112","authenticated-orcid":false,"given":"Sabrina","family":"Hense","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania","family":"Schink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan H.","family":"Kreisel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydie","family":"Marcelon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Simondon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maike","family":"Tahden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edeltraut","family":"Garbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"127","published-online":{"date-parts":[[2014,12,16]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1114525"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)67665-9"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.56.6.758"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s00115-012-3479-8"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.51.4.1110"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1086\/655136"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3329\/jhpn.v28i6.6602"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1086\/594124"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/77.3.1297"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d5956"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2012.7342"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d3908"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.08.106"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kws194"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2007.03.053"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/CND.0b013e3181aaa968"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.09.020"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1002\/pds.3220"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/pds.3321"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kws196"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1159\/000324710"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1529-8027.2007.00150.x"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61877-8"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1002\/pds.2038"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-10-360"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2011.0064"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1545"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a009523"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e5823"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1097\/00001648-199407000-00011"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410030628"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410270707"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.06.003"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.02.009"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1111\/j.1529-8027.2011.00356.x"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000316393.54258.d1"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410350228"}],"container-title":["Neuroepidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.karger.com\/Article\/Pdf\/369344","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.karger.com\/Article\/Pdf\/369344","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T18:00:51Z","timestamp":1745431251000},"score":1,"resource":{"primary":{"URL":"https:\/\/karger.com\/article\/doi\/10.1159\/000369344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":37,"journal-issue":{"issue":"3-4","published-online":{"date-parts":[[2015,1,1]]},"published-print":{"date-parts":[[2015,1,15]]}},"URL":"https:\/\/doi.org\/10.1159\/000369344","archive":["Portico"],"relation":{},"ISSN":["0251-5350","1423-0208"],"issn-type":[{"value":"0251-5350","type":"print"},{"value":"1423-0208","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]}}}